Meeting
2022 ASCO Annual Meeting
Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC).
Authors
Clara Hwang
Henry Ford Health System, Detroit, MI
Clara Hwang , Nicholas Henderson , Frank Cameron Cackowski , Amanda Pilling , Albert Jang , Shoshana Rothstein , Matthew Labriola , Joseph J. Park , Alyssa Ghose , Mehmet Asim Bilen , Deepak Kilari , Abhishek Tripathi , Rohan Garje , Vadim S Koshkin , Michael Thomas Schweizer , Andrew J. Armstrong , Rana R. McKay , Tanya B. Dorff , Ajjai Shivaram Alva , Pedro C. Barata
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5013)
DOI
10.1200/JCO.2022.40.16_suppl.5013
Abstract #
5013
Poster Bd #
197
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Genomic profiling of primary prostate tumors from patients who develop metastatic castration-resistant prostate cancer (mCRPC).
First Author: Joaquin Mateo
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.
First Author: Aishwarya Subramanian
Poster
2023 ASCO Annual Meeting
Clinical implications of molecular alterations in intraductal carcinoma of the prostate.
First Author: Benjamin Miron
Poster
2019 ASCO Annual Meeting
Ductal (PDC), acinar (PAC) and neuroendocrine (PNC) carcinomas of the prostate: A comparative comprehensive genomic profiling (CGP) study.
First Author: Gennady Bratslavsky